Attachment 7 - Sample Client Authorization Letter Amend 01.pdf
PDF 195 KB Posted
- Solicitation number
- 75F40123R00001
About this file
This solicitation requests proposals to provide on-site animal care and technical procedures services at the U.S. Food and Drug Administration's National Center for Toxicological Research. Offerors must provide superior care for all research animals, sanitize animal care and diet preparation facilities, and conduct protocol-specified technical procedures. Ancillary tasks include quality control, occupational safety and health compliance, inventory management, equipment maintenance, standard operating procedures development and training programs. The Performance Work Statement and four appendices in Attachment 1 describe historical and estimated workloads, government furnished property, facility floor plans, and the quality assurance surveillance plan. Offerors must submit pricing in Attachment 2 and confirm compliance with the applicable wage determination and collective bargaining agreement in Attachments 3 and 4. The solicitation also provides a past performance evaluation questionnaire template for client references in Attachment 7. Proposals are due by 2:00pm CDT on March 23, 2023 and must be submitted to the point of contact provided.
View the file
Other files
Show all 13
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
75F40123R00001 ATTACHMENT 7
SAMPLE CLIENT AUTHORIZATION LETTER
(Tra n sfer to Comp a n y Lett er h e a d )
Dear Client, We are currently responding to Solicitation Number 75F40123R00001 to provide animal care services and technical procedures for a base year and four (4) option years at the U.S. Food and Drug Administration (FDA) National Center for Toxicological Research
(NCTR).
The FDA has placed emphasis on past performance as a key source selection factor and requires that clients of entities responding to the solicitations be identified and their participation in the evaluation process be requested; therefore, enclosed is a (present and) Past Performance Evaluation Questionnaire (PPEQ) for your completion. We request that you complete the questionnaire and send it directly to the FDA, no later than 2:00 pm CDT on March 23, 2023 to Tim Walbert, Contract Specialist at timothy.walbert@fda.hhs.gov.
If you have questions or require assistance regarding the attached questionnaire, please contact Tim Walbert at the e-mail address shown above.
Thank you for your consideration and prompt response regarding this matter.
Sincerely, {Offering Entity} mailto:yolanda.rankin@fda.hhs.gov mailto:yolanda.rankin@fda.hhs.gov Timothy.Walbert Highlight
Timothy.Walbert Highlight
Timothy.Walbert Highlight added as part of amendment 01.
Timothy.Walbert Highlight
Timothy.Walbert Highlight
Timothy.Walbert Highlight
File details come from the government source that posted it. Updated .